Retatrutide 60 mg is a research-use-only lyophilized peptide vial associated with the Retatrutide scientific product family. Retatrutide, also known as LY3437943, is studied as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways in controlled laboratory research settings. Retatrutide is used in research investigating multi-receptor metabolic signaling, incretin receptor pharmacology, receptor co-activation, and downstream signaling pathway interactions. This product record represents the 60 mg commercial SKU and should be interpreted separately from batch-specific quality results, which are governed by COA and batch release documentation.